Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Profusa, Inc. Common Stock (PFSA)
USD1.93
-0.08 (-3.98%)
US NASDAQ Healthcare Medical - Equipment & Services
Address
5959 Horton Street, Suite 450, Emeryville, CA 94608 94608
EmeryVille, CA, US
EmeryVille, CA, US
CEO
Ben Chung-Bin Hwang
Website
profusa.com
IPO
2025-07-14
CIK 1859807 ISIN US74319X2071
Also trades on
NASDAQ · NVACR (USD)
NASDAQ Global Market · NVACW (USD)
NASDAQ Global Market · PFSA (USD)
Other OTC · NVAC (USD)
Description
Profusa, Inc. is a pioneering health technology firm that engineers advanced, bio-integrated sensors. These innovative devices, exemplified by their Lumee™ Oxygen Platform, are designed for uninterrupted observation of internal physiological markers. By leveraging artificial intelligence, Profusa translates this constant stream of data into actionable health insights, primarily to empower individuals and clinicians in the management of persistent health challenges like diabetes and critical limb ischemia.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD1.93
-0.08 (-3.98%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
7M
Beta
0.32
Float Shares
87.6K
Free Float %
15.7%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.50% | -8.57% | -40.54% | -65.92% | -97.21% | -95.49% | -99.81% | -99.81% | -99.81% | -99.81% | -99.81% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
1.93
Quality scores
Altman Z-Score
-436.74
Distress
Piotroski F-Score
2 / 9
Weak
MOAT Score
3 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
5 / 5
High
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Equipment & Services: +14.1%—
-
EPS growth Medical - Equipment & Services: +15.4%+70.0% ★ Q1'26: +100.0% (vs Q1'25)
-
FCF margin FCF growth · Medical - Equipment & Services: -3.5%—
-
EBIT margin Medical - Equipment & Services: +1.1%—
-
ROIC Medical - Equipment & Services: +2.4%— Q1'26: +99.9% (vs Q1'25)
-
Share dilution Medical - Equipment & Services: -2.1%+1,195.4% Q1'26: +489,793.3% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Equipment & Services: 0.31×-1.12× Q1'26: -0.78× (vs Q1'25)
Valuation Multiples
From
To
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-28 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-27 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-26 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-22 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-21 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-20 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-19 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-18 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-15 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
Owner's Earnings history not available.
Owner alignment
Owner's Earnings TTM
—
OE per share TTM
—
Owner's Yield
—
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
—
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
9
Total invested
36.2K
Insider transactions (90d)
2
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
9
-12 vs prev Q
New positions
4
Closed positions
16
Increased
6
Reduced
3
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | CITADEL ADVISORS LLC | 30.8K +30.8K (+100.0%) | 15.6K +15.6K (+100.0%) | 2.50% +2.503 pp | 0.00% +0.000 pp | USD0.51 +0.0% | 1 qtrs NEW |
| 2 | GEODE CAPITAL MANAGEMENT, LLC | 30.7K +30.7K (+100.0%) | 15.6K +15.6K (+100.0%) | 2.49% +2.493 pp | 0.00% +0.000 pp | USD0.51 +0.0% | 1 qtrs NEW |
| 3 | — | 3.9K +3.9K (+100.0%) | 2.0K +2.0K (+100.0%) | 0.32% +0.320 pp | 0.00% +0.000 pp | USD0.51 +0.0% | 1 qtrs NEW |
| 4 | VANGUARD FIDUCIARY TRUST CO | 1.7K +1.7K (+100.0%) | 859.00 +859.0 (+100.0%) | 0.14% +0.138 pp | 0.00% +0.000 pp | USD0.51 +0.0% | 1 qtrs NEW |
| 5 | MORGAN STANLEY | 1.6K +1.6K (+100.0%) | 811.00 +811.0 (+100.0%) | 0.13% +0.130 pp | 0.00% +0.000 pp | USD0.51 +0.0% | 1 qtrs NEW |
| 6 | FMR LLC | 13.00 +13.0 (+100.0%) | 7.00 +7.0 (+100.0%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD0.46 +10.9% | 1 qtrs NEW |
| 7 | GABELLI FUNDS LLC | — -14.5K (-100.0%) | — -1.5K (-100.0%) | 0.00% -0.016 pp | 0.00% +0.000 pp | USD— | 3 qtrs SOLD |
| 8 | GOLDMAN SACHS GROUP INC | — -17.9K (-100.0%) | — -1.9K (-100.0%) | 0.00% -0.019 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 9 | JANE STREET GROUP, LLC | — -86.9K (-100.0%) | — -9.1K (-100.0%) | 0.00% -0.094 pp | 0.00% +0.000 pp | USD— | 3 qtrs SOLD |
| 10 | BANK OF AMERICA CORP /DE/ | — -279.0 (-100.0%) | — -29.0 (-100.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD— | 3 qtrs SOLD |
| 11 | MINT TOWER CAPITAL MANAGEMENT B.V. | — -9.4K (-100.0%) | — -1.0K (-100.0%) | 0.00% -0.010 pp | 0.00% 0.000 pp | USD— | 3 qtrs SOLD |
| 12 | RVW WEALTH, LLC | — -29.3K (-100.0%) | — -3.1K (-100.0%) | 0.00% -0.032 pp | 0.00% 0.000 pp | USD— | 2 qtrs SOLD |
| 13 | SBI SECURITIES CO., LTD. | — -1.4K (-100.0%) | — -146.0 (-100.0%) | 0.00% -0.002 pp | 0.00% +0.000 pp | USD— | 3 qtrs SOLD |
| 14 | SG AMERICAS SECURITIES, LLC | — -13.5K (-100.0%) | — -1.0K (-100.0%) | 0.00% -0.015 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 15 | SKYVIEW INVESTMENT ADVISORS, LLC | — -20.0K (-100.0%) | — -2.0K (-100.0%) | 0.00% -0.022 pp | 0.00% 0.000 pp | USD— | 3 qtrs SOLD |
| 16 | TOWER RESEARCH CAPITAL LLC (TRC) | — -273.0 (-100.0%) | — -29.0 (-100.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD— | 3 qtrs SOLD |
| 17 | UBS GROUP AG | — -3.5M (-100.0%) | — -372.0K (-100.0%) | 0.00% -3.834 pp | 0.00% 0.000 pp | USD— | 3 qtrs SOLD |
| 18 | YAKIRA CAPITAL MANAGEMENT, INC. | — -74.6K (-100.0%) | — -7.8K (-100.0%) | 0.00% -0.081 pp | 0.00% -0.003 pp | USD— | 3 qtrs SOLD |
| 19 | LEO WEALTH, LLC | — -149.1K (-100.0%) | — -15.6K (-100.0%) | 0.00% -0.161 pp | 0.00% -0.001 pp | USD— | 3 qtrs SOLD |
| 20 | CETERA INVESTMENT ADVISERS | — -11.8K (-100.0%) | — -1.2K (-100.0%) | 0.00% -0.013 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 21 | CRESSET ASSET MANAGEMENT, LLC | — -10.9K (-100.0%) | — -1.1K (-100.0%) | 0.00% -0.012 pp | 0.00% +0.000 pp | USD— | 3 qtrs SOLD |
| 22 | D. E. SHAW & CO., INC. | — -15.0K (-100.0%) | — -1.6K (-100.0%) | 0.00% -0.016 pp | 0.00% +0.000 pp | USD— | 3 qtrs SOLD |
| 23 | EWA, LLC | — -27.4K (-100.0%) | — -2.9K (-100.0%) | 0.00% -0.030 pp | 0.00% -0.001 pp | USD— | 2 qtrs SOLD |
| 24 | GABELLI & CO INVESTMENT ADVISERS, INC. | — -10.5K (-100.0%) | — -1.1K (-100.0%) | 0.00% -0.011 pp | 0.00% 0.000 pp | USD— | 3 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 1 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Vanguard Extended Market ETF VXF | 0.00% | 1.4K | 0.05% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
0
Sells
2
Shares acquired
—
Shares disposed
—
Cash buys
2.00
Cash sales
—
Net activity
+0
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-04 | STOVER JACK E | Director | P-Purchase | D | Convertible Promissory Note | 0 | 0.35 | — | 0 | I | ↗ |
| 2026-05-04 | Knechtel Fred S. | Officer | P-Purchase | D | Convertible Promissory Note | 0 | 0.35 | — | 0 | I | ↗ |
| 2026-01-26 | STOVER JACK E | Director | J-Other | A | Warrants | 380,280 | 11.50 | 4.37M | 380,280 | D | ↗ |
| 2026-01-26 | O'Rourke Peter | Director | J-Other | A | Common Stock | 107,750 | 0.00 | — | 107,750 | D | ↗ |
| 2026-01-26 | NorthView Sponsor I, LLC | 10% Owner | J-Other | A | Warrants | 5,162,500 | 11.50 | 59.37M | 0 | D | ↗ |
| 2026-01-26 | Knechtel Fred S. | Officer | J-Other | A | Common Stock | 818,961 | 0.00 | — | 818,961 | D | ↗ |
| 2026-01-26 | Chung Lauren | Director | J-Other | A | Common Stock | 30,000 | 0.00 | — | 30,000 | D | ↗ |
| 2026-01-26 | Asarpota Rajesh | Director | A-Award | A | Stock Options | 221,794 | 0.35 | 77.6K | 221,794 | D | ↗ |
| 2025-07-11 | Hwang Ben Chung-Bin | Director / Officer | — | — | Common Stock | 0 | 0.00 | — | 477,342 | D | ↗ |
| 2025-07-11 | Asarpota Rajesh | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
Executive team
Top executives
Shares Outstanding
556.8K
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Ben Chung-Bin Hwang | Chief Executive Officer & Chairman | 2M | — |
| Fred S. Knechtel | Chief Financial Officer | 851.6K | male |
| David Icke | Head of Digital Health Business | — | male |
| Phil Constantinou | Head of Software & Data Science | — | male |
| Sean Givens | Head of Government Business | — | male |
| William McMillan | Co-founder, Chief Scientific Officer & Head of Research | — | male |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for PFSA
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
